Table:
begin	end	state
1	22	cytoplasmic
23	51	transmembrane
52	62	non-cytoplasmic
63	85	transmembrane
86	96	cytoplasmic
97	115	transmembrane
116	120	non-cytoplasmic
121	142	transmembrane
143	163	cytoplasmic
164	184	transmembrane
185	195	non-cytoplasmic
196	215	transmembrane
216	244	cytoplasmic
245	264	transmembrane
265	283	non-cytoplasmic
284	303	transmembrane
304	313	cytoplasmic
314	333	transmembrane
334	338	non-cytoplasmic
339	362	transmembrane
363	372	cytoplasmic
373	395	transmembrane
396	406	non-cytoplasmic
407	425	transmembrane
426	436	cytoplasmic

Input:
>RR42_RS21430 FitnessBrowser__Cup4G11:RR42_RS21430
MTDLSAPLLDAPPSAEEKRKRVYAIVAASSGNLVEWFDFYVYAFCAIYFAGSFFPKSDPT
AQLLNTAGVFAAGFLMRPIGGWLFGRIADRHGRKNSLLISVTMMCCGSLLIASLPTYNSI
GAWAPALLLVARLLQGLSVGGEYGTTATYMSEVALKGQRGFFSSFQYVTLIGGQLLAVLV
VVVLQQFLDEAELKAWGWRIPFVIGAITAVVALFLRRTLHETTSAATRASKEAGTLTELF
RNHKAAFFTVLGYTAGGSLIFYTFTTYMQKYLVNSAGMSIKTASYVMTGCLFFYMCMQPF
FGALSDRIGRRTNMLLFGALGTLATVPILTALGSVKSPFVAFALISLALAIVSLYTSISG
IVKAEMFPTEIRALGVGLAYAVANAIFGGSAEYVALDLKSLGHESSFYWYVTAMMVIVFL
VSFRLPRQARYLHHEH

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server